Work

The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models

Year: 2013

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-12-2293

Authors: Ymera Pignochino, Carmine Dell'Aglio, Marco Basiricò, Federica Capozzi, Marco Soster, Serena Marchiò, Stefania Bruno, Loretta Gammaitoni, Dario Sangiolo, Erica Torchiaro, Lorenzo D'Ambrosio, Franca Fagioli, Stefano Ferrari, Marco Alberghini, Piero Picci, Massimo Aglietta, Giovanni Grignani

Institutions: Ospedale Sant'Anna, Istituto Ortopedico Rizzoli, Ospedale Regina Margherita, Candiolo Cancer Institute, Fondazione Piemontese per la Ricerca sul Cancro Onlus, University of Turin

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2002121944

FWCI: 4.134

Cites: 37

Cited by: 107

Related to: 10